About Adi's research on Magnetic-Based Biosensing:

Adi's research is a part of Stanford Center for Cancer Nanotechnology Excellence (CCNE), and focuses on early detection of ovarian cancer by detecting the presence of specific protein biomarkers in an individual's blood serum using a giant magnetoresistance (GMR) spin-valve nanosensor. The GMR nanosensor is able to detect protein concentrations down to a femtomolar level with 6 decades (logs) of dynamic range. It is capable of performing multiplex in-vitro diagnostics of non-purified blood serums, allowing sensitive and rapid biomarker detection.

More specifically, Adi's work currently focuses on further improvement of the already-broad dynamic range of the nanosensor, and screening and validation of early-detection biomarker panels using samples from patients' blood serums. In addition, Adi also works on optimal nanofabrication of multilayered spin-valve GMR thin films using magnetron sputtering.